MARK A GOLDSMITH
CIK 1246842 · See Remarks · last filed 2026-06-18
MARK A GOLDSMITH is a corporate insider who has filed 106 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing shows the insider sold $1.6M of RVMDW on Jun 18, 2026. Across all open-market trades the lifetime net is −$61.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $133.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$133.82M
3
106
-$61.31M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RVMDW | See Remarks | 331,754 | $8.84 | $2.93M | -$48.50M | 30 | 2026-06-18 |
| RVMD | See Remarks | 711,879 | $183.86 | $130.89M | -$11.79M | 26 | 2023-10-24 |
| CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | Director | 89,857 | $33.99 | $3.05M | -$1.02M | 9 | 2021-06-04 |
Recent Filings
106 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-18 | RVMDW | Sell (S) | −10,020 | -$1.56M | EDGAR |
| 2026-06-15 | RVMD | Notice (144) | −9,772 | -$1.50M | EDGAR |
| 2026-04-17 | RVMDW | Mixed | — | -$17.46M | EDGAR |
| 2026-04-15 | RVMD | Notice (144) | −120,000 | -$17.64M | EDGAR |
| 2026-03-19 | RVMDW | Sell (S) | −12,871 | -$1.28M | EDGAR |
| 2026-03-13 | RVMD | Notice (144) | −13,261 | -$1.32M | EDGAR |
| 2026-03-03 | RVMDW | Mixed | +51,100 | -$3.52M | EDGAR |
| 2026-03-02 | RVMD | Notice (144) | −3,000 | -$306.1K | EDGAR |
| 2026-03-02 | RVMD | Notice (144) | −3,000 | -$306.1K | EDGAR |
| 2026-03-02 | RVMD | Notice (144) | −30,000 | -$3.06M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.